Loading…
Bruker Corporation completed the acquisition of an 80% majority interest in Hain Lifescience GmbH, a molecular diagnostics company based in Nehren, Germany.
Bruker Corporation has signed a definitive agreement to acquire an 80% majority interest in Hain Lifescience GmbH, a German molecular diagnostics company specializing in infectious disease testing. The acquisition is expected to close in Q4 2018. Financial details were not disclosed.